The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.
Jun 10, 2024
0
0
"Don't wake the bear that sleeps" is one of the central conclusions of a dissertation on medication for children before anesthesia and surgery. The effect of anti-anxiety, calming and sleep-inducing drugs can quickly wear ...
Jun 10, 2024
0
0
Australian and Chinese researchers have jointly discovered a genetic key to the development of the devastating autoimmune condition childhood lupus.
Jun 3, 2024
0
12
Implants that steadily release the right dose of a drug directly to the target part of the body have been a major advance in drug delivery. However, they still face some key challenges, such as ensuring the drug is released ...
Jun 3, 2024
0
0
A new analysis found that the profound benefits of Novo Nordisk's obesity drug Wegovy for people at risk of heart attacks or strokes don't depend on the number of the scale—cardiovascular health improves whether people ...
May 23, 2024
0
2
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to the results of a new KFF Health Tracking Poll, released ...
May 15, 2024
0
6
Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have found beneficial ...
May 14, 2024
0
0
People with a common heart condition were able to use significantly more oxygen while exercising after taking an investigational drug in an international clinical trial, according to a study published today in the New England ...
May 13, 2024
0
17
New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12–15 May) has found that poor muscle health is associated with a higher risk of an early death in people living with obesity.
May 10, 2024
1
36
About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.
May 10, 2024
0
0
